This interaction, linked to the desensitization and internalization of TRPV1 [187], positions CBD as a potential pharmacotherapeutic treatment in conditions where TRPV1′s inhibition is crucial, such as pain, epilepsy [188], and, potentially, glaucoma. The gene discussed is TRPV1; the disease is glaucoma.